{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T14:41:23Z","timestamp":1776696083859,"version":"3.51.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,7,16]],"date-time":"2007-07-16T00:00:00Z","timestamp":1184544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,7,16]],"date-time":"2007-07-16T00:00:00Z","timestamp":1184544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1038\/sj.bmt.1705770","type":"journal-article","created":{"date-parts":[[2007,7,16]],"date-time":"2007-07-16T15:12:46Z","timestamp":1184598766000},"page":"541-547","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2"],"prefix":"10.1038","volume":"40","author":[{"given":"Y S","family":"Chae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S K","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J G","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y Y","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J H","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H J","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J S","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G J","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D H","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-J","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y-K","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H-J","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,7,16]]},"reference":[{"key":"BF1705770_CR1","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1182\/blood-2002-06-1860","volume":"101","author":"GB McDonald","year":"2003","unstructured":"McDonald GB, Slattery JT, Bouvier ME, Ren S, Batchelder AL, Kalhorn TF et al. Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. Blood 2003; 101: 2043\u20132048.","journal-title":"Blood"},{"key":"BF1705770_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2165\/00003088-200241020-00002","volume":"41","author":"V Gandhi","year":"2002","unstructured":"Gandhi V, Plunkett W . Cellular and clinical pharmacology of fludarabine. Clin Pharmacokinet 2002; 41: 93\u2013103.","journal-title":"Clin Pharmacokinet"},{"key":"BF1705770_CR3","first-page":"1487","volume":"57","author":"L Li","year":"1997","unstructured":"Li L, Liu X, Glassman AB, Keating MJ, Stros M, Plunkett W et al. Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro. Cancer Res 1997; 57: 1487\u20131494.","journal-title":"Cancer Res"},{"key":"BF1705770_CR4","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756\u2013763.","journal-title":"Blood"},{"key":"BF1705770_CR5","first-page":"2254","volume":"7","author":"M Bornhauser","year":"2001","unstructured":"Bornhauser M, Thiede C, Platzbecker U, Jenke A, Helwig A, Plettig R et al. Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients. Clin Cancer Res 2001; 7: 2254\u20132262.","journal-title":"Clin Cancer Res"},{"key":"BF1705770_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1046\/j.1365-2257.2002.00461.x","volume":"24","author":"Y Murotani","year":"2002","unstructured":"Murotani Y, Kuroda J, Kimura S, Terao K, Fukiya E, Ozawa M et al. Non-myeloablative haematopoietic stem cell transplantation for severe aplastic anaemia with various complications. Clin Lab Haematol 2002; 24: 303\u2013306.","journal-title":"Clin Lab Haematol"},{"key":"BF1705770_CR7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1182\/blood-2002-02-0535","volume":"101","author":"R Or","year":"2003","unstructured":"Or R, Shapira MY, Resnick I, Amar A, Ackerstein A, Samuel S et al. Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase. Blood 2003; 101: 441\u2013445.","journal-title":"Blood"},{"key":"BF1705770_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1182\/blood-2004-02-0414","volume":"104","author":"M de Lima","year":"2004","unstructured":"de Lima M, Couriel D, Thall PF, Wang X, Madden T, Jones R et al. Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. Blood 2004; 104: 857\u2013864.","journal-title":"Blood"},{"key":"BF1705770_CR9","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1182\/blood-2002-11-3567","volume":"102","author":"M Bornhauser","year":"2003","unstructured":"Bornhauser M, Storer B, Slattery JT, Appelbaum FR, Deeg HJ, Hansen J et al. Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells. Blood 2003; 102: 820\u2013826.","journal-title":"Blood"},{"key":"BF1705770_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1053\/bbmt.2002.v8.pm12374451","volume":"8","author":"JA Russell","year":"2002","unstructured":"Russell JA, Tran HT, Quinlan D, Chaudhry A, Duggan P, Brown C et al. Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes. Biol Blood Marrow Transplant 2002; 8: 468\u2013476.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705770_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/sj.bmt.1705480","volume":"38","author":"S Chunduri","year":"2006","unstructured":"Chunduri S, Dobogai LC, Peace D, Saunthararajah Y, Chen HY, Mahmud N et al. Comparable kinetics of myeloablation between fludarabine\/full-dose busulfan and fludarabine\/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2006; 38: 477\u2013482.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705770_CR12","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1182\/blood.V80.5.1358.1358","volume":"80","author":"M Boeckh","year":"1992","unstructured":"Boeckh M, Bowden RA, Goodrich JM, Pettinger M, Meyers JD . Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 1992; 80: 1358\u20131364.","journal-title":"Blood"},{"key":"BF1705770_CR13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V57.2.267.267","volume":"57","author":"KM Sullivan","year":"1981","unstructured":"Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267\u2013276.","journal-title":"Blood"},{"key":"BF1705770_CR14","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705770_CR15","first-page":"939","volume":"90","author":"KH Lee","year":"2005","unstructured":"Lee KH, Choi SJ, Lee JH, Lee JS, Kim WK, Lee KB et al. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation. Haematologica 2005; 90: 939\u2013948.","journal-title":"Haematologica"},{"key":"BF1705770_CR16","first-page":"250","volume":"28","author":"KM Sullivan","year":"1991","unstructured":"Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250\u2013259.","journal-title":"Semin Hematol"},{"key":"BF1705770_CR17","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1177\/030089160108700224","volume":"87","author":"LD DeLeve","year":"2001","unstructured":"DeLeve LD . Hepatic venoocclusive disease: a major complication of hematopoietic stem cell transplantation in cancer patients. Tumori 2001; 87: S27\u2013S29.","journal-title":"Tumori"},{"key":"BF1705770_CR18","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/hep.510240414","volume":"24","author":"LD DeLeve","year":"1996","unstructured":"DeLeve LD . Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation. Hepatology 1996; 24: 830\u2013837.","journal-title":"Hepatology"},{"key":"BF1705770_CR19","first-page":"114","volume":"126","author":"HM Shulman","year":"1987","unstructured":"Shulman HM, Luk K, Deeg HJ, Shuman WB, Storb R . Induction of hepatic veno-occlusive disease in dogs. Am J Pathol 1987; 126: 114\u2013125.","journal-title":"Am J Pathol"},{"key":"BF1705770_CR20","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1200\/JCO.1996.14.5.1484","volume":"14","author":"JT Slattery","year":"1996","unstructured":"Slattery JT, Kalhorn TF, McDonald GB, Lambert K, Buckner CD, Bensinger WI et al. Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients. J Clin Oncol 1996; 14: 1484\u20131494.","journal-title":"J Clin Oncol"},{"key":"BF1705770_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/15258160050079407","volume":"9","author":"JL Ferrara","year":"2000","unstructured":"Ferrara JL . Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors. J Hematother Stem Cell Res 2000; 9: 299\u2013306.","journal-title":"J Hematother Stem Cell Res"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705770.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705770","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705770.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:44:57Z","timestamp":1648082697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,16]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["BF1705770"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705770","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,16]]},"assertion":[{"value":"8 March 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}